Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study.

Miguel Garcia-PardoLaura OrtegaMaría Jesús Fernández-AceñeroPilar García AlfonsoMiguel MartínAndrés J Muñoz

Published in: Journal of gastrointestinal cancer (2021)

Comprehensive genomic profiling (CGP) in cholangiocarcinoma can identify, in a high proportion of patients, clinically relevant genomic alterations that can lead to targeted therapies, expanding treatment options.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cross sectional
copy number
prognostic factors
peritoneal dialysis
gene expression
patient reported outcomes
dna methylation
genome wide